hTEE Symposium during the 33rd Annual ISHLT


Montreal, Canada
April 24th, 2013

Multidisciplinary heart failure and transplant teams from across the world joined us at the hTEE Symposium on April 24th during the ISHLT 33rd Annual Meeting in Montreal, Canada. Here they heard from physicians how hTEE is used to optimize the care of transplant, ventricular assist device and extracorporeal membrane oxygenation patients. Turnout was high, and the clinical discussion was extremely rewarding.

Four leaders in critical care cardiac surgery, including Margarita Camacho, MD and Claudia Gidea, MD from Newark Beth Israel, Nicholas Cavarocchi, MD from Thomas Jefferson University Hospital, and Peter Lee, MD, MPH, from Stanford University Medical Center, shared a firsthand overview of the impact hTEE has made in their respective practices.

"hTEE has been an invaluable tool, and it has made a huge impact in our practice. I have been waiting for this technology for 20 years," commented Margarita Camacho MD during the symposium.

"Direct visualization of ventricular function reduces the complexity associated with the post-operative care of heart failure patients," said Peter Lee MD, Cardiothoracic Surgeon at Stanford Hospital. "hTEE has become an essential tool in our ICU to meet the critical, patient management needs created by use of these evolving, life-saving MCS technologies."

"The key to hTEE's impact on the care of MCS patients is the ability to assess the RV," commented Scott Roth MD, the Co-Founder/CMO of ImaCor. "RV dysfunction is prevalent in MCS patients, compounding their already high-risk profile. hTEE continuously provides a window to the RV, enabling clinicians to manage dysfunction from its inception. There is simply no other way to do this easily at the ICU bedside."

"Hospitals using hTEE on complex patients, i.e., MCS, are seeing the benefit via improved outcomes and reduction in complication costs," stated Peter Pellerito, President/CEO of ImaCor. "At yesterday's symposium, physicians once again underscored the synergistic use of technology – matching costly, complex patients and technologies with the cost-effective, simplified hTEE approach."

We thank our distinguished presenters for their efforts in educating their peers on hTEE.